annual FCF:
$414.30M+$3.57B(+113.14%)Summary
- As of today (April 12, 2025), LLY annual free cash flow is $414.30 million, with the most recent change of +$3.57 billion (+113.14%) on December 31, 2024.
- During the last 3 years, LLY annual FCF has fallen by -$4.97 billion (-92.31%).
- LLY annual FCF is now -93.35% below its all-time high of $6.23 billion, reached on December 31, 2008.
Performance
LLY Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
$726.60M+$1.19B(+258.34%)Summary
- As of today (April 12, 2025), LLY quarterly free cash flow is $726.60 million, with the most recent change of +$1.19 billion (+258.34%) on December 31, 2024.
- Over the past year, LLY quarterly FCF has stayed the same.
- LLY quarterly FCF is now -65.48% below its all-time high of $2.10 billion, reached on December 31, 2008.
Performance
LLY quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$414.30M+$2.69B(+118.21%)Summary
- As of today (April 12, 2025), LLY TTM free cash flow is $414.30 million, with the most recent change of +$2.69 billion (+118.21%) on December 31, 2024.
- Over the past year, LLY TTM FCF has stayed the same.
- LLY TTM FCF is now -93.35% below its all-time high of $6.23 billion, reached on December 31, 2008.
Performance
LLY TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
LLY Free cash flow Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +113.1% | 0.0% | 0.0% |
3 y3 years | -92.3% | -12.2% | -89.1% |
5 y5 years | -88.1% | -12.2% | -89.1% |
LLY Free cash flow Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -92.3% | +113.1% | -55.8% | +137.0% | -92.9% | +110.6% |
5 y | 5-year | -92.3% | +113.1% | -63.2% | +137.0% | -92.9% | +110.6% |
alltime | all time | -93.3% | +113.1% | -65.5% | +137.0% | -93.3% | +110.6% |
Eli Lilly and Company Free cash flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | $414.30M(-113.1%) | $726.60M(-258.3%) | $414.30M(-118.2%) |
Sep 2024 | - | -$458.90M(-823.8%) | -$2.28B(-37.3%) |
Jun 2024 | - | $63.40M(-23.8%) | -$3.63B(-6.9%) |
Mar 2024 | - | $83.20M(-104.2%) | -$3.90B(+23.6%) |
Dec 2023 | -$3.15B(-168.5%) | -$1.96B(+8.4%) | -$3.15B(+1811.5%) |
Sep 2023 | - | -$1.81B(+786.4%) | -$164.90M(-105.1%) |
Jun 2023 | - | -$204.40M(-124.7%) | $3.21B(-15.2%) |
Mar 2023 | - | $827.10M(-19.2%) | $3.79B(-17.7%) |
Dec 2022 | $4.60B(-14.6%) | $1.02B(-34.5%) | $4.60B(-13.8%) |
Sep 2022 | - | $1.56B(+323.2%) | $5.34B(+7.9%) |
Jun 2022 | - | $369.70M(-77.5%) | $4.95B(-15.0%) |
Mar 2022 | - | $1.64B(-6.8%) | $5.82B(+8.1%) |
Dec 2021 | $5.39B(+20.5%) | $1.76B(+49.9%) | $5.39B(+16.6%) |
Sep 2021 | - | $1.18B(-5.5%) | $4.62B(-4.5%) |
Jun 2021 | - | $1.24B(+3.2%) | $4.84B(-13.1%) |
Mar 2021 | - | $1.21B(+21.1%) | $5.56B(+24.5%) |
Dec 2020 | $4.47B(+28.3%) | $995.70M(-28.4%) | $4.47B(-12.5%) |
Sep 2020 | - | $1.39B(-29.4%) | $5.11B(+4.6%) |
Jun 2020 | - | $1.97B(+1675.2%) | $4.89B(+32.7%) |
Mar 2020 | - | $111.10M(-93.2%) | $3.68B(+5.8%) |
Dec 2019 | $3.48B(+39.0%) | $1.64B(+40.1%) | $3.48B(+30.4%) |
Sep 2019 | - | $1.17B(+52.6%) | $2.67B(-19.6%) |
Jun 2019 | - | $766.20M(-958.0%) | $3.32B(+49.9%) |
Mar 2019 | - | -$89.30M(-110.8%) | $2.22B(-11.5%) |
Dec 2018 | $2.51B(-27.4%) | $825.00M(-54.7%) | $2.51B(-14.5%) |
Sep 2018 | - | $1.82B(-634.8%) | $2.93B(+15.3%) |
Jun 2018 | - | -$340.70M(-270.4%) | $2.54B(-41.0%) |
Mar 2018 | - | $200.00M(-84.0%) | $4.31B(+24.9%) |
Dec 2017 | $3.45B(-8.2%) | $1.25B(-12.8%) | $3.45B(-7.8%) |
Sep 2017 | - | $1.43B(+0.3%) | $3.74B(-0.0%) |
Jun 2017 | - | $1.43B(-316.3%) | $3.74B(+7.9%) |
Mar 2017 | - | -$660.90M(-142.9%) | $3.47B(-7.6%) |
Dec 2016 | $3.76B(+180.9%) | $1.54B(+7.5%) | $3.76B(+41.4%) |
Sep 2016 | - | $1.43B(+24.0%) | $2.66B(+32.5%) |
Jun 2016 | - | $1.16B(-409.7%) | $2.01B(+39.5%) |
Mar 2016 | - | -$373.40M(-184.5%) | $1.44B(+7.5%) |
Dec 2015 | $1.34B(-53.7%) | $441.90M(-43.4%) | $1.34B(-14.8%) |
Sep 2015 | - | $781.20M(+32.7%) | $1.57B(-26.6%) |
Jun 2015 | - | $588.70M(-224.4%) | $2.14B(-9.0%) |
Mar 2015 | - | -$473.40M(-170.3%) | $2.35B(-18.8%) |
Dec 2014 | $2.89B(-37.7%) | $673.80M(-50.1%) | $2.89B(-14.9%) |
Sep 2014 | - | $1.35B(+68.9%) | $3.40B(-10.3%) |
Jun 2014 | - | $799.00M(+1036.6%) | $3.79B(-15.6%) |
Mar 2014 | - | $70.30M(-94.1%) | $4.49B(-3.3%) |
Dec 2013 | $4.64B(+8.9%) | $1.18B(-32.0%) | $4.64B(+0.6%) |
Sep 2013 | - | $1.74B(+15.8%) | $4.61B(+9.7%) |
Jun 2013 | - | $1.50B(+577.6%) | $4.20B(+10.8%) |
Mar 2013 | - | $221.50M(-80.8%) | $3.79B(-11.0%) |
Dec 2012 | $4.26B(-23.1%) | $1.15B(-13.3%) | $4.26B(-10.7%) |
Sep 2012 | - | $1.33B(+21.6%) | $4.77B(-7.7%) |
Jun 2012 | - | $1.09B(+58.7%) | $5.17B(-7.3%) |
Mar 2012 | - | $688.20M(-58.6%) | $5.57B(+0.6%) |
Dec 2011 | $5.54B(-2.3%) | $1.66B(-3.7%) | $5.54B(-5.0%) |
Sep 2011 | - | $1.72B(+15.1%) | $5.83B(+2.6%) |
Jun 2011 | - | $1.50B(+128.0%) | $5.68B(+2.5%) |
Mar 2011 | - | $657.10M(-66.4%) | $5.54B(-2.2%) |
Dec 2010 | $5.67B(+62.9%) | $1.95B(+24.0%) | $5.67B(+5.2%) |
Sep 2010 | - | $1.58B(+16.1%) | $5.39B(+9.0%) |
Jun 2010 | - | $1.36B(+73.4%) | $4.94B(+14.1%) |
Mar 2010 | - | $782.90M(-53.2%) | $4.33B(+24.5%) |
Dec 2009 | $3.48B(-44.1%) | $1.67B(+47.8%) | $3.48B(-11.1%) |
Sep 2009 | - | $1.13B(+51.6%) | $3.91B(-16.6%) |
Jun 2009 | - | $746.40M(-1180.2%) | $4.69B(-0.7%) |
Mar 2009 | - | -$69.10M(-103.3%) | $4.73B(-24.1%) |
Dec 2008 | $6.23B(+52.9%) | $2.10B(+10.2%) | $6.23B(+4.0%) |
Sep 2008 | - | $1.91B(+145.1%) | $5.98B(+13.2%) |
Jun 2008 | - | $779.50M(-45.5%) | $5.29B(+9.0%) |
Mar 2008 | - | $1.43B(-23.2%) | $4.85B(+19.1%) |
Dec 2007 | $4.07B | $1.86B(+53.4%) | $4.07B(+11.4%) |
Sep 2007 | - | $1.21B(+254.8%) | $3.66B(+9.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2007 | - | $342.30M(-47.5%) | $3.34B(-3.3%) |
Mar 2007 | - | $652.40M(-54.9%) | $3.46B(+19.3%) |
Dec 2006 | $2.90B(+370.9%) | $1.45B(+60.8%) | $2.90B(+57.1%) |
Sep 2006 | - | $900.30M(+97.3%) | $1.85B(+501.8%) |
Jun 2006 | - | $456.30M(+386.5%) | $306.60M(+109.0%) |
Mar 2006 | - | $93.80M(-76.2%) | $146.70M(-76.2%) |
Dec 2005 | $615.50M(-36.6%) | $394.70M(-161.8%) | $615.50M(+105.7%) |
Sep 2005 | - | -$638.20M(-315.3%) | $299.20M(-76.6%) |
Jun 2005 | - | $296.40M(-47.3%) | $1.28B(-9.8%) |
Mar 2005 | - | $562.60M(+617.6%) | $1.42B(+46.2%) |
Dec 2004 | $971.40M(-49.9%) | $78.40M(-77.2%) | $971.40M(-30.7%) |
Sep 2004 | - | $343.50M(-21.2%) | $1.40B(-19.4%) |
Jun 2004 | - | $436.10M(+284.6%) | $1.74B(-0.2%) |
Mar 2004 | - | $113.40M(-77.7%) | $1.74B(-10.2%) |
Dec 2003 | $1.94B(+106.4%) | $508.80M(-25.3%) | $1.94B(+11.8%) |
Sep 2003 | - | $680.70M(+54.6%) | $1.74B(+33.1%) |
Jun 2003 | - | $440.20M(+41.8%) | $1.30B(+8.2%) |
Mar 2003 | - | $310.40M(+2.1%) | $1.20B(+28.2%) |
Dec 2002 | $939.80M(-66.2%) | $304.10M(+22.1%) | $939.80M(-33.0%) |
Sep 2002 | - | $249.00M(-27.0%) | $1.40B(-28.4%) |
Jun 2002 | - | $341.20M(+649.9%) | $1.96B(-20.0%) |
Mar 2002 | - | $45.50M(-94.1%) | $2.45B(-11.8%) |
Dec 2001 | $2.78B(-9.0%) | $767.20M(-4.7%) | $2.78B(-2.4%) |
Sep 2001 | - | $805.40M(-3.1%) | $2.85B(-8.9%) |
Jun 2001 | - | $831.40M(+122.5%) | $3.12B(+6.7%) |
Mar 2001 | - | $373.60M(-55.3%) | $2.93B(-4.1%) |
Dec 2000 | $3.05B(+46.0%) | $835.00M(-22.9%) | $3.05B(+3.1%) |
Sep 2000 | - | $1.08B(+70.6%) | $2.96B(+1.3%) |
Jun 2000 | - | $635.10M(+27.0%) | $2.92B(+5.0%) |
Mar 2000 | - | $500.20M(-32.7%) | $2.79B(+33.2%) |
Dec 1999 | $2.09B(-5.4%) | $743.10M(-29.0%) | $2.09B(-7.0%) |
Sep 1999 | - | $1.05B(+111.1%) | $2.25B(+16.3%) |
Jun 1999 | - | $495.70M(-355.6%) | $1.93B(-5.1%) |
Mar 1999 | - | -$193.90M(-121.6%) | $2.04B(-7.9%) |
Dec 1998 | $2.21B(+8.6%) | $899.70M(+23.0%) | $2.21B(+4.4%) |
Sep 1998 | - | $731.60M(+22.1%) | $2.12B(+17.5%) |
Jun 1998 | - | $599.00M(-3036.3%) | $1.80B(+1.9%) |
Mar 1998 | - | -$20.40M(-102.5%) | $1.77B(-13.0%) |
Dec 1997 | $2.03B(+31.4%) | $806.40M(+93.6%) | $2.03B(+10.1%) |
Sep 1997 | - | $416.60M(-26.4%) | $1.85B(+3.6%) |
Jun 1997 | - | $566.10M(+131.1%) | $1.78B(+6.6%) |
Mar 1997 | - | $245.00M(-60.5%) | $1.67B(+8.1%) |
Dec 1996 | $1.55B(+21.5%) | $620.40M(+76.1%) | $1.55B(+0.8%) |
Sep 1996 | - | $352.30M(-22.6%) | $1.54B(+14.0%) |
Jun 1996 | - | $454.90M(+279.4%) | $1.35B(+11.7%) |
Mar 1996 | - | $119.90M(-80.3%) | $1.21B(-5.3%) |
Dec 1995 | $1.27B(+33.2%) | $608.40M(+271.4%) | $1.27B(+30.0%) |
Sep 1995 | - | $163.80M(-47.9%) | $979.50M(-19.8%) |
Jun 1995 | - | $314.20M(+68.1%) | $1.22B(+12.4%) |
Mar 1995 | - | $186.90M(-40.6%) | $1.09B(+13.7%) |
Dec 1994 | $955.80M(+8.2%) | $314.60M(-22.3%) | $955.80M(-0.1%) |
Sep 1994 | - | $405.00M(+125.0%) | $957.10M(+5.6%) |
Jun 1994 | - | $180.00M(+220.3%) | $906.30M(+0.4%) |
Mar 1994 | - | $56.20M(-82.2%) | $902.30M(+2.1%) |
Dec 1993 | $883.40M(+83.5%) | $315.90M(-10.8%) | $883.40M(+0.6%) |
Sep 1993 | - | $354.20M(+101.3%) | $878.10M(+36.4%) |
Jun 1993 | - | $176.00M(+371.8%) | $644.00M(+44.3%) |
Mar 1993 | - | $37.30M(-88.0%) | $446.40M(-7.3%) |
Dec 1992 | $481.40M(+329.1%) | $310.60M(+158.6%) | $481.40M(+75.6%) |
Sep 1992 | - | $120.10M(-656.0%) | $274.20M(-19.4%) |
Jun 1992 | - | -$21.60M(-129.9%) | $340.30M(+41.4%) |
Mar 1992 | - | $72.30M(-30.1%) | $240.60M(+114.4%) |
Dec 1991 | $112.20M(-76.0%) | $103.40M(-44.5%) | $112.20M(+190.7%) |
Sep 1991 | - | $186.20M(-253.5%) | $38.60M(-64.6%) |
Jun 1991 | - | -$121.30M(+116.2%) | $109.10M(-60.0%) |
Mar 1991 | - | -$56.10M(-288.3%) | $272.60M(-41.6%) |
Dec 1990 | $467.10M(-2.3%) | $29.80M(-88.4%) | $467.10M(+6.8%) |
Sep 1990 | - | $256.70M(+508.3%) | $437.30M(+142.1%) |
Jun 1990 | - | $42.20M(-69.5%) | $180.60M(+30.5%) |
Mar 1990 | - | $138.40M | $138.40M |
Dec 1989 | $478.10M | - | - |
FAQ
- What is Eli Lilly and Company annual free cash flow?
- What is the all time high annual FCF for Eli Lilly and Company?
- What is Eli Lilly and Company annual FCF year-on-year change?
- What is Eli Lilly and Company quarterly free cash flow?
- What is the all time high quarterly FCF for Eli Lilly and Company?
- What is Eli Lilly and Company quarterly FCF year-on-year change?
- What is Eli Lilly and Company TTM free cash flow?
- What is the all time high TTM FCF for Eli Lilly and Company?
- What is Eli Lilly and Company TTM FCF year-on-year change?
What is Eli Lilly and Company annual free cash flow?
The current annual FCF of LLY is $414.30M
What is the all time high annual FCF for Eli Lilly and Company?
Eli Lilly and Company all-time high annual free cash flow is $6.23B
What is Eli Lilly and Company annual FCF year-on-year change?
Over the past year, LLY annual free cash flow has changed by +$3.57B (+113.14%)
What is Eli Lilly and Company quarterly free cash flow?
The current quarterly FCF of LLY is $726.60M
What is the all time high quarterly FCF for Eli Lilly and Company?
Eli Lilly and Company all-time high quarterly free cash flow is $2.10B
What is Eli Lilly and Company quarterly FCF year-on-year change?
Over the past year, LLY quarterly free cash flow has changed by $0.00 (0.00%)
What is Eli Lilly and Company TTM free cash flow?
The current TTM FCF of LLY is $414.30M
What is the all time high TTM FCF for Eli Lilly and Company?
Eli Lilly and Company all-time high TTM free cash flow is $6.23B
What is Eli Lilly and Company TTM FCF year-on-year change?
Over the past year, LLY TTM free cash flow has changed by $0.00 (0.00%)